Q1 Earnings Estimate for Cibus Issued By HC Wainwright

Cibus, Inc. (NASDAQ:CBUS) – Research analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of Cibus in a research report issued to clients and investors on Friday, March 21st. HC Wainwright analyst A. Dayal expects that the company will earn ($0.66) per share for the quarter. HC Wainwright currently has a “Buy” rating and a $25.00 target price on the stock. The consensus estimate for Cibus’ current full-year earnings is ($2.96) per share. HC Wainwright also issued estimates for Cibus’ Q2 2025 earnings at ($0.67) EPS, Q3 2025 earnings at ($0.69) EPS, Q4 2025 earnings at ($0.70) EPS and FY2029 earnings at $1.36 EPS.

Separately, Canaccord Genuity Group reduced their target price on Cibus from $20.00 to $18.00 and set a “buy” rating for the company in a report on Wednesday, January 22nd.

Cibus Stock Performance

CBUS opened at $2.09 on Monday. The company has a market cap of $55.29 million, a PE ratio of -0.09 and a beta of 2.04. The stock has a 50-day moving average of $2.32 and a 200-day moving average of $3.28. Cibus has a 52-week low of $1.80 and a 52-week high of $23.18.

Cibus (NASDAQ:CBUS) last posted its earnings results on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing the consensus estimate of ($0.68) by ($0.19). Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. The business had revenue of $1.21 million for the quarter, compared to analyst estimates of $1.13 million.

Institutional Investors Weigh In On Cibus

A number of hedge funds have recently bought and sold shares of the company. FMR LLC increased its stake in shares of Cibus by 16.9% in the third quarter. FMR LLC now owns 3,913,279 shares of the company’s stock worth $12,757,000 after purchasing an additional 566,328 shares during the period. Granby Capital Management LLC increased its position in Cibus by 300.0% in the 4th quarter. Granby Capital Management LLC now owns 200,000 shares of the company’s stock worth $556,000 after buying an additional 150,000 shares during the period. Renaissance Technologies LLC lifted its holdings in shares of Cibus by 933.3% during the fourth quarter. Renaissance Technologies LLC now owns 127,100 shares of the company’s stock worth $353,000 after buying an additional 114,800 shares during the last quarter. State Street Corp lifted its holdings in shares of Cibus by 43.6% during the third quarter. State Street Corp now owns 307,262 shares of the company’s stock worth $1,002,000 after buying an additional 93,236 shares during the last quarter. Finally, Certior Financial Group LLC bought a new stake in shares of Cibus in the fourth quarter valued at approximately $236,000. 33.81% of the stock is currently owned by institutional investors.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.